This inventor holds 2 USPTO granted patents. Top assignees: University of California, Syntex (u.s.a.) Inc., Syntex LLC. Active years: 1988-1989.
Company Filing History:
2 out of 15,977 
1 out of 932 
1 out of 47 Years Active: 1988-1989
Title: The Innovative Contributions of Philip Crews
Introduction
Philip Crews is a notable inventor based in Santa Cruz, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, his work has garnered attention for its potential impact on health and medicine.
Latest Patents
Among his latest patents, Crews has developed "Bengamide anthelmintics," which are novel .delta.-caprolactam derivatives that exhibit anti-tumor, antibiotic, and anthelmintic activity. The formula includes variations where R can be H, lower alkyl, or lower acyl. Another significant patent is focused on "Oxazole anthelmintic agents of marine origin," which presents new oxazole derivatives and their pharmacologically acceptable salts that also demonstrate anthelmintic activity, with R being H, OH, or acyloxy of 8 to 22 carbon atoms.
Career Highlights
Philip Crews has had a distinguished career, working with reputable institutions such as the University of California and Syntex Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Crews has collaborated with several talented individuals, including Madeline Adamczeski and Thomas R Matthews. These partnerships have further enriched his research and innovation efforts.
Conclusion
Philip Crews stands out as an influential inventor whose work in pharmaceuticals has the potential to advance medical treatments. His patents reflect a commitment to innovation and a desire to improve health outcomes through scientific discovery.